Zucker School of Medicine at Hofstra/Northwell’s Division of Kidney Diseases is interviewing for a AST-certified transplant nephrology fellowship.

Zucker School of Medicine at Hofstra/Northwell is now interviewing for the Galdi Fellowship

Dr. Akshta Pai, MD, MPH is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra. She is the Director of Strategic Development and Outreach for kidney transplantatio…

This multicenter cohort study evaluates the association of prophylactic intravenous magnesium with cisplatin-associated acute kidney injury in patients treated with cisplatin chemotherapy.

As summer approaches, Steven Fishbane, MD, talks about who needs more (or fewer) electrolytes

The United Network for Organ Sharing says there are nearly 8,000 people waiting for a lifesaving transplant in New York.

AbstractBackground. IgA nephropathy (IgAN) can cause hypertension, and severe hypertension can exacerbate the progression of IgAN. However, the long-term k

Nephrotic syndrome (NS) carries a significantly elevated risk of venous thromboembolic events (VTE), contributing to morbidity and mortality. Current guidelines for VTE prophylaxis in NS are based on limited evidence, primarily from observational studies. This review describes the complexities of hypercoagulability in NS, focusing on aspirin as a potential prophylactic agent. We outline the pathophysiology underlying VTE in NS, highlighting factors such as hypoalbuminemia, loss of anticoagulants, and heightened platelet reactivity.

Abstract. Background Kidney transplant is a treatment of choice for end-stage kidney disease, with longer survival and better quality of life post-transplant. However, long-term immunosuppression come...

One platform for interactive learning, engagement and collaborative knowledge

A confluence of innovative therapeutics and public-policy initiatives afford nephrology an opportunity to pivot from managing kidney diseases to preserving kidney health. The Advancing American Kidney...

ABSTRACTBackground. Cancer is a leading cause of death among patients on hemodialysis; however, the data on its diagnosis, treatment and prognosis are limi